NAVELLIER & ASSOCIATES INC - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 30 filers reported holding SINOVAC BIOTECH LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NAVELLIER & ASSOCIATES INC ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q3 2023$014,6490.0%0.00%
Q2 2023$014,649
-2.7%
0.00%
Q1 2023$015,0560.0%0.00%
Q4 2022$015,056
+1.3%
0.00%
Q3 2022$014,867
-6.1%
0.00%
Q2 2022$015,8280.0%0.00%
Q1 2022$015,828
-28.6%
0.00%
Q4 2021$022,1780.0%0.00%
Q3 2021$022,178
-0.3%
0.00%
Q2 2021$022,2480.0%0.00%
Q1 2021$022,2480.0%0.00%
Q4 2020$022,248
-2.4%
0.00%
Q3 2020$022,786
-2.6%
0.00%
Q2 2020$023,387
-3.1%
0.00%
Q1 2020$0
-100.0%
24,141
-2.7%
0.00%
-100.0%
Q4 2019$161,00024,822
-8.7%
0.03%
Q3 2019$027,1900.0%0.00%
Q2 2019$027,1900.0%0.00%
Q1 2019$0
-100.0%
27,190
-6.1%
0.00%
-100.0%
Q4 2018$201,000
-14.1%
28,953
-5.9%
0.03%
+13.3%
Q3 2018$234,000
-1.7%
30,760
-3.5%
0.03%
-9.1%
Q2 2018$238,000
+70.0%
31,865
+28.5%
0.03%
+450.0%
Q2 2014$140,000
-21.8%
24,8000.0%0.01%
-25.0%
Q1 2014$179,000
+184.1%
24,800
+142.0%
0.01%
+166.7%
Q4 2013$63,00010,2500.00%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Orbimed Advisors 2,718,735$340,500,0006.32%
Vivo Capital, LLC 5,900,000$38,173,0004.21%
Neumann Advisory Hong Kong Ltd 315,586$2,0420.72%
Yorktown Management & Research Co Inc 74,893$485,0000.63%
Skandinaviska Enskilda Banken AB (publ) 40,000$259,0000.00%
Renaissance Technologies 2,375,841$1,537,0000.00%
WELLS FARGO & COMPANY/MN 1,687$11,0000.00%
NORTHERN TRUST CORP 13,787$55,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 412$27,0000.00%
View complete list of SINOVAC BIOTECH LTD shareholders